First patient treated in Clarity's therapeutic prostate canc

Highlights Clarity Pharmaceuticals recruits and treats its first patient in the therapeutic phase of its SAR-bisPSMA theranostic clinical trial SECuRE...

Related Keywords

United States , Omaha , Nebraska , Sydney , New South Wales , Australia , American , Alan Taylor , Luke Nordquist , National Cancer Institute , Technology Platform , Urology Cancer Center , Clarity Pharmaceuticals , Cancer Statistics Center , Safety Review Committee , Gu Research Network In Omaha , American Cancer Society , Targeted Copper Theranostics , Prostate Specific Membrane Antigen , Urologic Medical Oncologist , Principal Investigator , Executive Chairman , Targeted Copper Theranostic , Cancer Statistics , Mortality Worldwide , Cancer Society ,